OrthoPediatrics Corp.

NASDAQ:KIDS

Medical - Devices

Healthcare
$31.65 +1.05%

+$0.19 today

Market cap
$826.40M
Beta
1.01
P/E (TTM)
-11.0
EPS (TTM)
-$1.68
52W Low $14.42High $23.70

Volume 0.16M

Average 0.16M

KIDS Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

OrthoPediatrics Corp.NASDAQ: KIDS

Net Receivables · Q1 FY2026 · quarter ended Mar 2026

Net receivables rises 23.7% from a year ago

Net receivables stood at $54.43M at the end of Q1 FY2026, up 23.7% from a year earlier and up 1.1% from the prior quarter. Over 3 fiscal years it compounded at +29.5% a year.

Context

  • Net receivables amounted to 10.8% of total assets at the end of Q1 FY2026, up 1.5 pp from a year earlier.
  • Net receivables increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether net receivables keeps rising in the next quarterly balance sheet after a +23.7% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$54.43M+1.1% QoQ
Last fiscal yearDec 2025
$53.84M+27.1% YoY
Year agoMar 2025
$43.99M+23.7% since
Net Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+23.7%——
1 year+27.1%——
3-year CAGR+29.5%——
5-year CAGR——
10-year CAGR——

Net Receivables history

USD · from the balance sheet

Latest · FY2025
53.84M USD
Year-over-year change
+27.1%
4-year CAGR
+31.6%

Net Receivables vs competitors

How KIDS compares with its peers on the latest reported figures

  • KIDS's Mar 2026 net receivables of $54.43M is the 3rd highest of the 8 companies compared; the peer median is $30.36M.
  • Its year-over-year change of +23.7% is the 2nd highest of 8, against a peer median of +2.1%.
  • Net receivables amounts to 10.8% of total assets for KIDS, versus a peer median of 16.5%.
KIDS Competitors Peer median
Net Receivables for KIDS and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
BVSBioventus Inc.Mar 2026$120.53M +2.1%-2.0%18.5%
TOIThe Oncology Institute, Inc.Mar 2026$59.45M +19.7%+13.6%35.3%
KIDSOrthoPediatrics Corp.Mar 2026$54.43M +23.7%+29.5%10.8%
EOLSEvolus, Inc.Mar 2026$52.22M +10.0%+34.6%23.7%
TMCITreace Medical Concepts, Inc.Mar 2026$30.36M -2.4%+13.0%16.5%
RXSTRxSight, Inc.Mar 2026$22.44M -27.5%+28.8%7.4%
LABStandard BioTools Inc.Mar 2026$16.64M -53.1%-8.1%2.6%
CBLLCeriBell, Inc.Mar 2026$15.71M +39.1%+41.7%8.8%
Peer median (excluding KIDS) $30.36M+2.1%+13.6%16.5%

Competitors are the stored peer set for KIDS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents9.01M8.99M31.06M43.82M19.56M
Short-term Investments45.9M109.3M49.25M25.01M41.3M
Net Receivables17.94M24.8M34.62M42.36M53.84M
Inventory57.57M78.19M105.85M117.01M133.79M
Other Current Assets3.23M1.47M5.72M1.96M7.94M
Total Current Assets133.65M226.72M226.5M237.17M256.42M
Property, Plant & Equipment (Net)28.52M34.29M41.05M58.83M49.56M
Goodwill72.35M86.82M83.7M93.84M109.27M
Intangible Assets69.76M79.9M84.56M81.18M77.71M
Long-term Investments0189.52M1.86M2.18M0
Tax Assets4.13M5.95M000
Other Non-current Assets0(195.48M)1.09M015.68M
Total Non-current Assets174.75M201.01M212.25M236.04M252.21M
Total Assets308.4M427.73M438.75M473.21M508.63M
Account Payables9.33M11.15M12.65M8.91M18.79M
Short-term Debt13M144K152K160K170K
Tax Payables00000
Deferred Revenue05.95M000
Other Current Liabilities2.04M6.88M7.39M8.89M16.64M
Total Current Liabilities29.72M30.87M41.67M33.96M46.2M
Long-term Debt15.22M763K9.91M72.96M99.82M
Deferred Tax Liabilities8.9M5.95M5.48M03.58M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities28.91M11.49M4.66M6.06M12.44M
Total Non-current Liabilities53.32M18.21M20.05M84.68M115.84M
Total Liabilities83.03M49.08M61.72M118.64M162.03M
Common Stock5K6K6K6K6K
Retained Earnings(178.03M)(176.77M)(197.74M)(235.56M)(275.21M)
Accumulated OCI8.49M(5.4M)(5.53M)(10.77M)(523K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity225.37M378.65M377.03M354.57M346.6M
Total Debt28.51M907K10.06M80.9M99.99M
Net Debt19.5M(8.08M)(21M)37.08M80.43M

OrthoPediatrics Corp.

NASDAQ:KIDS

Intrinsic Alpha fair value

Locked

Current Price

$31.65

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.